These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 19896708
1. miR-138 might reverse multidrug resistance of leukemia cells. Zhao X, Yang L, Hu J, Ruan J. Leuk Res; 2010 Aug; 34(8):1078-82. PubMed ID: 19896708 [Abstract] [Full Text] [Related]
2. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Zhang H, Li M, Han Y, Hong L, Gong T, Sun L, Zheng X. Dig Dis Sci; 2010 Sep; 55(9):2545-51. PubMed ID: 19960259 [Abstract] [Full Text] [Related]
3. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C, Bhalla K. Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089 [Abstract] [Full Text] [Related]
4. Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line. Zhai X, Lu J, Wang Y, Fang F, Li B, Gu W. J Tradit Chin Med; 2014 Dec; 34(6):678-83. PubMed ID: 25618972 [Abstract] [Full Text] [Related]
5. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Li X, Hong L, Zhao Y, Jin H, Fan R, Du R, Xia L, Luo G, Fan D. Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532 [Abstract] [Full Text] [Related]
6. Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression. Liang R, Chen XQ, Bai QX, Wang Z, Zhang T, Yang L, Dong BX, Gao GX, Gu HT, Zhu HF. Acta Haematol; 2014 Dec; 132(2):177-86. PubMed ID: 24603438 [Abstract] [Full Text] [Related]
7. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein. Wu CH, Rastegar M, Gordon J, Safa AR. Oncogene; 2001 Oct 25; 20(48):7006-20. PubMed ID: 11704825 [Abstract] [Full Text] [Related]
8. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway. Lin KN, Jiang YL, Zhang SG, Huang SY, Li H. Biomed Pharmacother; 2020 May 25; 125():109885. PubMed ID: 32007917 [Abstract] [Full Text] [Related]
9. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells. Lopes EC, Scolnik M, Alvarez E, Hajos SE. Leuk Res; 2001 Jan 25; 25(1):85-93. PubMed ID: 11137565 [Abstract] [Full Text] [Related]
10. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. Stein U, Walther W, Shoemaker RH. J Natl Cancer Inst; 1996 Oct 02; 88(19):1383-92. PubMed ID: 8827016 [Abstract] [Full Text] [Related]
11. Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells. Kim SS, Seong S, Lim SH, Kim SY. Anticancer Res; 2013 Nov 02; 33(11):4913-9. PubMed ID: 24222129 [Abstract] [Full Text] [Related]
12. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L. Leuk Lymphoma; 2012 Jul 02; 53(7):1383-9. PubMed ID: 22185283 [Abstract] [Full Text] [Related]
13. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y, Cao S, Qiao T, Chen Z, Fan D. Mol Cancer Ther; 2005 Dec 02; 4(12):1936-42. PubMed ID: 16373708 [Abstract] [Full Text] [Related]
14. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression. Chao CC. FEBS Lett; 1995 Oct 16; 373(3):285-90. PubMed ID: 7589484 [Abstract] [Full Text] [Related]
15. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y. Oncol Rep; 2010 May 16; 23(5):1469-75. PubMed ID: 20372866 [Abstract] [Full Text] [Related]
16. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells. Deng LM, Tan T, Zhang TY, Xiao XF, Gu H. Int J Oncol; 2019 Aug 16; 55(2):451-461. PubMed ID: 31268161 [Abstract] [Full Text] [Related]
17. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study. Ivy SP, Olshefski RS, Taylor BJ, Patel KM, Reaman GH. Blood; 1996 Jul 01; 88(1):309-18. PubMed ID: 8704189 [Abstract] [Full Text] [Related]
18. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D. Int J Cancer; 2008 Jul 15; 123(2):372-379. PubMed ID: 18449891 [Abstract] [Full Text] [Related]
19. [Multidrug resistance mechanisms in cell line HL-60/VCR]. Zhu XH, Li JY, Xia XM, Zhu MQ, Geng MJ, Chen L, Zhang JQ. Ai Zheng; 2002 Dec 15; 21(12):1310-3. PubMed ID: 12520737 [Abstract] [Full Text] [Related]
20. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Barancík M, Bohácová V, Kvackajová J, Hudecová S, Krizanová O, Breier A. Eur J Pharm Sci; 2001 Aug 15; 14(1):29-36. PubMed ID: 11457647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]